Correction to: Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature.

Autor: Sarode GV; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of California Davis, 4150 V Street, Suite 3500, Sacramento, CA, 95817, USA., Kim K; Division of Biostatistics, Department of Public Health Sciences, University of California Davis, Davis, CA, USA., Kieffer DA; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of California Davis, 4150 V Street, Suite 3500, Sacramento, CA, 95817, USA., Shibata NM; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of California Davis, 4150 V Street, Suite 3500, Sacramento, CA, 95817, USA., Litwin T; Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland., Czlonkowska A; Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland., Medici V; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of California Davis, 4150 V Street, Suite 3500, Sacramento, CA, 95817, USA. vmedici@ucdavis.edu.
Jazyk: angličtina
Zdroj: Metabolomics : Official journal of the Metabolomic Society [Metabolomics] 2019 Dec 03; Vol. 16 (1), pp. 3. Date of Electronic Publication: 2019 Dec 03.
DOI: 10.1007/s11306-019-1623-1
Abstrakt: In the originally published version of this article, there was an error. The metabolomics platform used for the analysis is GC-TOF-MS, Gas Chromatography Time-of-Flight Mass Spectrometry and not Hydrophilic Interaction Liquid Chromatography-Quadrupole Time of Flight Mass Spectrometry as indicated in the original version.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje